Adverum Biotechnologies, Inc.
ADVM
$3.08
$0.051.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 29.14% | 19.31% | |||
| Gross Profit | -29.14% | -19.31% | |||
| SG&A Expenses | -34.63% | -48.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.39% | -22.50% | |||
| Operating Income | -3.39% | 22.50% | |||
| Income Before Tax | -4.62% | 22.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.62% | 22.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.62% | 22.32% | |||
| EBIT | -3.39% | 22.50% | |||
| EBITDA | -3.75% | 22.59% | |||
| EPS Basic | -4.26% | 22.47% | |||
| Normalized Basic EPS | -4.26% | 22.47% | |||
| EPS Diluted | -4.26% | 22.47% | |||
| Normalized Diluted EPS | -4.26% | 22.47% | |||
| Average Basic Shares Outstanding | 0.34% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||